For the quarter ended March 2025, Brixmor Property (BRX) reported revenue of $337.51 million, up 5.4% over the same period last year. EPS came in at $0.56, compared to $0.29 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $330.56 million, representing a surprise of +2.11%. The company delivered an EPS surprise of +1.82%, with the consensus EPS estimate being $0.55. View all Key Company Metrics for Brixmor here>>> Shares of Brixmor have returned -1.3% over the past m ...

Company Performance - NETSTREIT (NTST) reported quarterly funds from operations (FFO) of $0.32 per share, exceeding the Zacks Consensus Estimate of $0.31 per share, and showing an increase from $0.31 per share a year ago, representing an FFO surprise of 3.23% [1] - The company achieved revenues of $45.91 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 1.43%, compared to revenues of $37.67 million in the same quarter last year [2] - Over the last four quarters, NETSTREIT has exceeded consensus FFO estimates three times and topped consensus revenue estimates four times [2] Stock Performance - NETSTREIT shares have increased approximately 10.4% since the beginning of the year, contrasting with the S&P 500's decline of -6.1% [3] - The current consensus FFO estimate for the upcoming quarter is $0.31 on revenues of $45.91 million, while for the current fiscal year, it is $1.27 on revenues of $179.97 million [7] Industry Outlook - The REIT and Equity Trust - Other industry, to which NETSTREIT belongs, is currently ranked in the bottom 31% of over 250 Zacks industries, indicating potential challenges ahead [8] - The performance of NETSTREIT's stock may be influenced by the overall outlook for the industry, as research indicates that the top 50% of Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1 [8]

Core Insights - The U.S. construction sector is experiencing a deceleration, influenced by high borrowing costs, labor shortages, material price volatility, and regulatory complexity [1] Group 1: Sector Performance - Public sector investments in infrastructure and manufacturing have supported growth, while residential remodeling and selective new home construction have posed challenges [1] - The construction sector's total earnings have decreased by 20% year-over-year, with revenues down by 4.2% [2] - Approximately 35.3% of the construction sector's market capitalization on the S&P 500 Index has reported earnings, with 57.1% beating EPS estimates and 42.9% surpassing revenue estimates [2] Group 2: Influencing Factors - Federal spending through the Infrastructure Investment and Jobs Act (IIJA) has been a significant tailwind, particularly in transportation, water infrastructure, and broadband projects [3] - Industrial construction projects related to the CHIPS Act and Inflation Reduction Act have also contributed to growth, focusing on semiconductor fabs, EV battery plants, and clean energy facilities [3] Group 3: Residential Market Challenges - The residential construction market faces high mortgage rates, seasonal impacts, inflationary pressures, and rising costs, which have negatively affected performance [4] - Homebuilders are under pressure due to increased incentives and lower average selling prices, impacting margins [4] Group 4: Commercial Construction Insights - The commercial construction market shows mixed but resilient performance, with industrial and warehouse projects benefiting from e-commerce and supply chain reshoring [5] - Data center construction is gaining traction due to cloud computing and AI infrastructure needs, while hospitality construction is recovering alongside rebounding travel [5] Group 5: Q1 Earnings Expectations - The construction sector is expected to see a 12.8% decline in earnings for Q1, a decrease from the previous quarter's growth of 1.1% [6] - Revenues are projected to decline by 3.3%, indicating a slowdown from the prior quarter's growth of 1.6% [6] Group 6: Company Highlights - Dream Finders Homes is expected to report a first-quarter EPS of 61 cents, reflecting a 10.9% growth year-over-year [11] - Primoris Services anticipates a first-quarter EPS of 72 cents, representing a 53.2% increase from the previous year [13] - Potlatch is projected to report a first-quarter EPS of 20 cents, improving from break-even earnings a year ago [14] - Martin Marietta Materials expects a first-quarter EPS of $1.92, a slight decline from the previous year [15] - MasTec is likely to report a first-quarter EPS of 34 cents, indicating a significant 361.5% growth year-over-year [16]

General Motors Co GM is set to report its first-quarter earnings on Tuesday before the market opens. Wall Street expects earnings per share of $2.73 on revenues of $43.15 billion.The stock has gained 2.65% over the past year but remains down 8% year-to-date, as tariff headlines and macro noise kept the auto sector spinning its wheels.Let's take a look at what the charts are signaling for GM stock ahead of earnings.Read Also: Automakers Are Struggling With Tariffs And EV Competition, Say AnalystsGM Technical ...

Becton Dickinson and Company (BDX) , popularly known as BD, is scheduled to report second-quarter fiscal 2025 results on May 1, before market open.In the last reported quarter, the company’s earnings per share (EPS) of $3.43 surpassed the Zacks Consensus Estimate by 15.1%. Over the trailing four quarters, its earnings outperformed the Zacks Consensus Estimate on all occasions, delivering an earnings surprise of 7.3%, on average. (See the Zacks Earnings Calendar to stay ahead of market-making news.)Let’s che ...

Amcor Plc (AMCR) is scheduled to report third-quarter fiscal 2025 results on April 30, after the closing bell.The Zacks Consensus Estimate for AMCR’s fiscal third-quarter revenues is pegged at $3.51 billion, indicating 2.9% growth from the year-ago reported figure.The consensus estimate for earnings is pegged at 18 cents per share. The consensus estimate indicates in-line results with the year-ago quarter. The estimate has moved down 5.3% in the past 60 days.  Image Source: Zacks Investment Research AMCR’s ...

Core Viewpoint - The market anticipates a year-over-year decline in Cummins' earnings due to lower revenues, with a focus on how actual results compare to estimates impacting stock price [1][2]. Earnings Expectations - Cummins is expected to report quarterly earnings of $4.82 per share, reflecting a year-over-year decrease of 5.5% [3]. - Revenue projections stand at $8.07 billion, which is a 4% decline from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised down by 7.13% over the last 30 days, indicating a bearish sentiment among analysts regarding the company's earnings prospects [4][10]. - The Most Accurate Estimate is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -1.79% [10][11]. Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that a positive or negative reading indicates the likely deviation of actual earnings from consensus estimates, with positive readings being more predictive of earnings beats [5][7]. - Stocks with a positive Earnings ESP and a Zacks Rank of 1, 2, or 3 have historically shown a nearly 70% chance of delivering a positive surprise [8]. Historical Performance - In the last reported quarter, Cummins exceeded the expected earnings of $4.68 per share by delivering $5.16, resulting in a surprise of +10.26% [12]. - Over the past four quarters, Cummins has beaten consensus EPS estimates three times [13]. Conclusion - Despite the potential for an earnings beat, various factors can influence stock movement, making it essential to consider other elements beyond just earnings results [14][16].

Wall Street expects a year-over-year decline in earnings on lower revenues when Clorox (CLX) reports results for the quarter ended March 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on May 5. On the other h ...

Core Viewpoint - The market anticipates New Jersey Resources (NJR) will report a year-over-year increase in earnings driven by higher revenues for the quarter ending March 2025, with actual results being crucial for stock price movement [1][2]. Earnings Expectations - NJR is expected to post quarterly earnings of $1.65 per share, reflecting a year-over-year increase of +17.9%, and revenues are projected to be $731.72 million, up 11.2% from the previous year [3]. Estimate Revisions - The consensus EPS estimate has been revised 750% lower in the last 30 days, indicating a significant reassessment by analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that the Most Accurate Estimate is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +1.21%, indicating a likelihood of beating the consensus EPS estimate [10][11]. Historical Performance - In the last reported quarter, NJR exceeded the expected earnings of $1.14 per share by delivering $1.29, resulting in a surprise of +13.16%. Over the last four quarters, the company has beaten consensus EPS estimates two times [12][13]. Investment Considerations - While NJR appears to be a strong candidate for an earnings beat, other factors should also be considered when making investment decisions [14][16].

Company Overview - ADC Therapeutics SA (ADCT) is anticipated to report a year-over-year increase in earnings due to higher revenues for the quarter ended March 2025, with a consensus outlook indicating a quarterly loss of $0.38 per share, reflecting a +32.1% change from the previous year [1][3] - Expected revenues for ADC Therapeutics are projected at $18.15 million, which is a slight increase of 0.6% compared to the same quarter last year [3] Earnings Estimates and Revisions - The consensus EPS estimate has been revised 8.33% higher in the last 30 days, indicating a reassessment by analysts of their initial estimates [4] - The Most Accurate Estimate for ADC Therapeutics aligns with the Zacks Consensus Estimate, resulting in an Earnings ESP of 0%, suggesting no recent differing analyst views [10][11] Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive or negative reading can predict the likelihood of actual earnings deviating from consensus estimates, with a positive ESP being a strong predictor of an earnings beat, especially when combined with a Zacks Rank of 1, 2, or 3 [6][8] - ADC Therapeutics currently holds a Zacks Rank of 3, making it challenging to predict a definitive earnings beat [11] Historical Performance - In the last reported quarter, ADC Therapeutics was expected to post a loss of $0.35 per share but actually reported a loss of $0.29, resulting in a surprise of +17.14% [12] - Over the past four quarters, the company has surpassed consensus EPS estimates two times [13] Industry Context - In the Zacks Medical - Biomedical and Genetics industry, Cardiff Oncology (CRDF) is expected to report a loss of $0.19 per share for the same quarter, indicating a year-over-year change of +13.6% [17] - Cardiff Oncology's revenue is projected to be $0.17 million, down 19.1% from the previous year, but it has an Earnings ESP of 24.32% and a Zacks Rank of 2, suggesting a higher likelihood of beating the consensus EPS estimate [18]